The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Diabetic kidney disease: a report from an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153
Preventing Medication Errors: Quality Chasm Series
(2007) · doi:10.17226/11623 · Cited by 829
Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563 · cited 1×
“rapid-acting insulin in relation to meals, reduced infusion rate of intravenous dextrose, unexpected interruption of enteral or parenteral feedings, delayed or missed blood glucose checks, and altered ability of the patient to report symptoms (5).”
BackgroundAgiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
Multiple hospitalizations for patients with diabetes
Jiang, H. J., Stryer, D., Friedman, B., & Andrews, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1421 · Cited by 261
Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1988 · Cited by 222
Hospital readmission of patients with diabetes
Rubin, D. J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0584-7 · Cited by 159 · cited 1×
“status; scheduled home health visits and timelyoutpatient follow-up reduceratesof readmission (106,107).”
BackgroundRoberts, A., James, J., Dhatariya, K., & Care, T. J. B. D. S. (. F. I. (2018) · Diabetic Medicine · doi:10.1111/dme.13675 · Cited by 158
Korytkowski, M. T., Salata, R. J., Koerbel, G. L., Selzer, F., Karslioglu, E., Idriss, A. M., Lee, K. K. W., Moser, A. J., & Toledo, F. G. S. (2009) · Diabetes Care · doi:10.2337/dc08-1436 · Cited by 149
Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries
van den Boom, W., Schroeder, R. A., Manning, M. W., Setji, T. L., Fiestan, G.-O., & Dunson, D. B. (2018) · Diabetes Care · doi:10.2337/dc17-2232 · Cited by 140
Umpierrez, G. E., Reyes, D., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Pasquel, F., Jacobs, S., Newton, C., Peng, L., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0479 · Cited by 130
Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related
Akirov, A., Grossman, A., Shochat, T., & Shimon, I. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2653 · Cited by 127 · cited 1×
“While hypoglycemia is associated with increased mortality (64), in”
BackgroundIntensive versus intermediate glucose control in surgical intensive care unit patients
Okabayashi, T., Shima, Y., Sumiyoshi, T., Kozuki, A., Tokumaru, T., Iiyama, T., Sugimoto, T., Kobayashi, M., Yokoyama, M., & Hanazaki, K. (2014) · Diabetes Care · doi:10.2337/dc13-1771 · Cited by 119
Bellido, V., Suarez, L., Rodriguez, M. G., Sanchez, C., Dieguez, M., Riestra, M., Casal, F., Delgado, E., Menendez, E., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-0160 · Cited by 118
Hsia, E., Seggelke, S., Gibbs, J., Hawkins, R. M., Cohlmia, E., Rasouli, N., Wang, C., Kam, I., & Draznin, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1244 · Cited by 112
Baldwin, D., Zander, J., Munoz, C., Raghu, P., DeLange-Hudec, S., Lee, H., Emanuele, M. A., Glossop, V., Smallwood, K., & Molitch, M. (2012) · Diabetes Care · doi:10.2337/dc12-0578 · Cited by 103
Garg, R., Schuman, B., Bader, A., Hurwitz, S., Turchin, A., Underwood, P., Metzger, C., Rein, R., & Lortie, M. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002323 · Cited by 103
Rushakoff, R. J., Sullivan, M. M., MacMaster, H. W., Shah, A. D., Rajkomar, A., Glidden, D. V., & Kohn, M. A. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1413 · Cited by 91
Fayfman, M., Galindo, R. J., Rubin, D. J., Mize, D. L., Anzola, I., Urrutia, M. A., Ramos, C., Pasquel, F. J., Haw, J. S., Vellanki, P., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1760 · Cited by 85
Vellanki, P., Rasouli, N., Baldwin, D., Alexanian, S., Anzola, I., Urrutia, M., Cardona, S., Peng, L., Pasquel, F. J., Umpierrez, G. E., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13587 · Cited by 80
Diabetic ketoacidosis: A common debut of diabetes among African Americans with type 2 diabetes
Vellanki, P., & Umpierrez, G. E. (2017) · Endocrine Practice · doi:10.4158/ep161679.ra · Cited by 73
Rickels, M. R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14214 · Cited by 71
Curll, M., DiNardo, M., Noschese, M., & Korytkowski, M. T. (2010) · Quality and Safety in Health Care · doi:10.1136/qshc.2008.027441 · Cited by 57
Bueno, E., Benitez, A., Rufinelli, J., Figueredo, R., Alsina, S., Ojeda, A., Samudio, S., Cáceres, M., Argüello, R., Romero, F., et al. (2015) · Endocrine Practice · doi:10.4158/ep15675.or · Cited by 56 · cited 2×
“If oral intake is poor, a safer procedure is to administer prandial insulin immediately after the patient eats, with the dose adjusted to be appropriate for the amount ingested (46).”
BackgroundPasquel, F. J., Gomez-Huelgas, R., Anzola, I., Oyedokun, F., Haw, J. S., Vellanki, P., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-1835 · Cited by 55
Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management
Maynard, G., Kulasa, K., Ramos, P., Childers, D., Clay, B., Sebasky, M., Fink, E., Field, A., Renvall, M., Juang, P. S., et al. (2015) · Endocrine Practice · doi:10.4158/ep14367.or · Cited by 52 · cited 1×
“found that hypoglycemic events fell by 56–80% (68,69).”
BackgroundRisk of hypoglycemia following hospital discharge in patients with diabetes and acute kidney injury
Hung, A. M., Siew, E. D., Wilson, O. D., Perkins, A. M., Greevy, R. A., Horner, J., Abdel-Kader, K., Parr, S. K., Roumie, C. L., Griffin, M. R., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1237 · Cited by 49
Drincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Harrison, V. S., Rustico, S., Palladino, A. A., Ferrara, C., & Hawkes, C. P. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12462 · Cited by 43 · cited 1×
“2–4 h prior to the intravenous insulin being stopped to prevent recurrence of ketoacidosis and rebound hyperglycemia (100).”
BackgroundSeggelke, S. A., Gibbs, J., & Draznin, B. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.874 · Cited by 42
Fushimi, N., Shibuya, T., Yoshida, Y., Ito, S., Hachiya, H., & Mori, A. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13093 · Cited by 41
Amori, R. E., Pittas, A. G., Siegel, R. D., Kumar, S., Chen, J. S., Karnam, S., Golden, S. H., & Salem, D. N. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.535 · Cited by 40
Hypoglycemia in Type 1 Diabetes Mellitus: Pathophysiology and Prevention
Dagogo-Jack, S. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00004 · Cited by 40
Pérez-Belmonte, L. M., Osuna-Sánchez, J., Millán-Gómez, M., López-Carmona, M. D., Gómez-Doblas, J. J., Cobos-Palacios, L., Sanz-Cánovas, J., Barbancho, M. A., Lara, J. P., Jiménez-Navarro, M., et al. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1613672 · Cited by 36
Shomali, M. E., Herr, D. L., Hill, P. C., Pehlivanova, M., Sharretts, J. M., & Magee, M. F. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0124 · Cited by 31
Temporal occurrences and recurrence patterns of hypoglycemia during hospitalization
Ulmer, B. J., Kara, A., & Mariash, C. N. (2015) · Endocrine Practice · doi:10.4158/ep14355.or · Cited by 28 · cited 1×
“have their dose of basal insulin changed before the next insulin administration (73).”
BackgroundZhang, R., Isakow, W., Kollef, M. H., & Scott, M. G. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002572 · Cited by 25
Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system
Milligan, P. E., Bocox, M. C., Pratt, E., Hoehner, C. M., Krettek, J. E., & Dunagan, W. C. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150077 · Cited by 24
U-500 regular insulin use in hospitalized patients
Tripathy, P. R., & Lansang, M. C. (2015) · Endocrine Practice · doi:10.4158/ep14151.or · Cited by 23 · cited 2×
“For patients transitioning to regimens with concentrated insulin (U-200, U-300, or U-500) in the inpatient setting, it is important to ensure correct dosing by utilizing an individual pen and cartridge for each patient and by meticulous supervision of the dose administered (55,56).”
BackgroundMethod
Cited by
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., De Hert, S., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,141
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
Endocrine toxicities of immune checkpoint inhibitors
Wright, J. J., Powers, A. C., & Johnson, D. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00484-3 · Cited by 441
Pop-Busui, R., Januzzi, J. L., Bruemmer, D., Butalia, S., Green, J. B., Horton, W. B., Knight, C., Levi, M., Rasouli, N., & Richardson, C. R. (2022) · Diabetes Care · doi:10.2337/dci22-0014 · Cited by 399
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-04
- Volume
- 44
- Issue
- Supplement_1
- Pages
- S211-S220
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4248302664
- Cited by
- 197
- References
- 45
- FWCI
- 23.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.